Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
Kinya Tsubota, Yoshihiko Usui, Yoshihiro Wakabayashi, Jun Suzuki, Shunichiro Ueda, Hiroshi GotoDepartment of Ophthalmology, Tokyo Medical University Hospital, Tokyo, JapanPurpose: This study aimed to elucidate the effects of intravitreal bevacizumab (IVB) injections for the prevention of post-vitrec...
Guardado en:
Autores principales: | Tsubota K, Usui Y, Wakabayashi Y, Suzuki J, Ueda S, Goto H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b05092cfe2164f4ca72a9bf47a968033 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
por: Shakarchi FI, et al.
Publicado: (2018) -
Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
por: Yusuke Kameda, et al.
Publicado: (2021) -
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho G, et al.
Publicado: (2020) -
Prefilled syringes for intravitreal drug delivery
por: Sassalos TM, et al.
Publicado: (2019) -
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata S, et al.
Publicado: (2019)